{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T08:05:45Z","timestamp":1779264345980,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["U01AI069924"],"award-info":[{"award-number":["U01AI069924"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["207285"],"award-info":[{"award-number":["207285"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2025,3,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Burkitt lymphoma (BL) may be HIV-associated but data on BL trends in South Africa (SA), where HIV is highly prevalent, are scarce. We compared BL incidence trends over 36 years among Black African and White individuals.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We included histologically diagnosed BL from the National Cancer Registry in SA between 1986\u20132021. We computed yearly age-standardised incidence rates (ASIR) by race, and annual percentage changes in ASIR using Joinpoint regression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Between 1986\u20132021, 2205 Black African (ASIR: 1.68\/1,000,000; 95% confidence interval [CI] 1.63\u20131.73) and 366 White individuals (ASIR: 2.34\/1,000,000; 95% CI 2.15\u20132.53) had incident BL. Median age at diagnosis increased over time, while the male proportion among those diagnosed declined. The ASIR among Black Africans increased from 1986\u20132012 and declined thereafter with BL incidence peaks shifting from children and elderly to middle-aged adults. Among White individuals, BL rates rose among all age\u00a0groups over time.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The BL epidemiology among Black Africans, with decreasing rates since 2012, may reflect SA\u2019s evolving HIV epidemic. In contrast, BL rates among White individuals in SA and many high-income countries continue to increase over time. Further studies are needed to better understand the differences in BL epidemiology across geographic regions and population groups.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1038\/s41416-024-02937-8","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T19:57:19Z","timestamp":1736884639000},"page":"462-468","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Patterns of incident Burkitt lymphoma during the HIV epidemic among the Black African and White population in South Africa"],"prefix":"10.1038","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1331-8280","authenticated-orcid":false,"given":"Carole","family":"Metekoua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yann","family":"Ruffieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Mwansa-Kambafwile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Kellett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Egger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1955-923X","authenticated-orcid":false,"given":"Mazvita","family":"Muchengeti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliane","family":"Rohner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8761-2162","authenticated-orcid":false,"given":"Tracey","family":"Wiggill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"2937_CR1","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","volume":"379","author":"EM Molyneux","year":"2012","unstructured":"Molyneux EM, Rochford R, Griffin B, Newton R, Jackson G, Menon G, et al. Burkitt\u2019s lymphoma. Lancet. 2012;379:1234\u201344.","journal-title":"Lancet"},{"key":"2937_CR2","first-page":"812","volume":"16","author":"JP Gastwirt","year":"2018","unstructured":"Gastwirt JP, Roschewski M. Management of adults with Burkitt lymphoma. Clin Adv Hematol Oncol. 2018;16:812\u201322.","journal-title":"Clin Adv Hematol Oncol"},{"key":"2937_CR3","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3390\/hemato3030030","volume":"3","author":"SM Mbulaiteye","year":"2022","unstructured":"Mbulaiteye SM, Devesa SS. Burkitt lymphoma incidence in five continents. Hemato. 2022;3:434\u201353.","journal-title":"Hemato"},{"key":"2937_CR4","doi-asserted-by":"crossref","unstructured":"L\u00f3pez C, Burkhardt B, Chan JKC, Leoncini L, Mbulaiteye SM, Ogwang MD, et al. Burkitt lymphoma. Nat Rev Dis Primers. 2022;8:78.","DOI":"10.1038\/s41572-022-00404-3"},{"key":"2937_CR5","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1002\/ijc.24934","volume":"126","author":"SM Mbulaiteye","year":"2010","unstructured":"Mbulaiteye SM, Anderson WF, Bhatia K, Rosenberg PS, Linet MS, Devesa SS. Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973-2005. Int J Cancer. 2010;126:1732\u20139.","journal-title":"Int J Cancer"},{"key":"2937_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13027-019-0228-7","volume":"14","author":"T Dhokotera","year":"2019","unstructured":"Dhokotera T, Bohlius J, Spoerri A, Egger M, Ncayiyana J, Olago V, et al. The burden of cancers associated with HIV in the South African public health sector, 2004-2014: a record linkage study. Infect Agent Cancer. 2019;14:1\u201312.","journal-title":"Infect Agent Cancer"},{"key":"2937_CR7","doi-asserted-by":"publisher","first-page":"e495","DOI":"10.1016\/S2352-3018(17)30125-X","volume":"4","author":"RU Hern\u00e1ndez-Ram\u00edrez","year":"2017","unstructured":"Hern\u00e1ndez-Ram\u00edrez RU, Shiels MS, Dubrow R, Engels EA. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. Lancet HIV. 2017;4:e495\u2013504.","journal-title":"Lancet HIV"},{"key":"2937_CR8","doi-asserted-by":"crossref","unstructured":"Mdletshe N, Nel A, Shires K, Mowla S. HIV Nef enhances the expression of oncogenic c-MYC and activation-induced cytidine deaminase in Burkitt lymphoma cells, promoting genomic instability. Infect Agent Cancer. 2020;15:54.","DOI":"10.1186\/s13027-020-00320-9"},{"key":"2937_CR9","doi-asserted-by":"crossref","unstructured":"Felli MP, Mowla S, Alves L, Rios S, Mapekula L, Mdletshe N, et al. HIV-1 transactivator of transcription (Tat) co-operates with AP-1 factors to enhance c-MYC transcription. Front Cell Dev Biol. 2021;9:693706.","DOI":"10.3389\/fcell.2021.693706"},{"key":"2937_CR10","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1002\/ijc.29494","volume":"137","author":"D Martorelli","year":"2015","unstructured":"Martorelli D, Muraro E, Mastorci K, Dal Col J, Fa\u00e8 DA, Furlan C, et al. A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting. Int J Cancer. 2015;137:1374\u201385.","journal-title":"Int J Cancer"},{"key":"2937_CR11","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","volume":"20","author":"EA Engels","year":"2006","unstructured":"Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, Mcneel TS, Scoppa SM, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS. 2006;20:1645\u201354.","journal-title":"AIDS"},{"key":"2937_CR12","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1158\/1055-9965.EPI-13-0040","volume":"22","author":"MS Shiels","year":"2013","unstructured":"Shiels MS, Engels EA, Linet MS, Clarke CA, Li J, Hall HI, et al. The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009. Cancer Epidemiol Biomark Prev. 2013;22:1069\u201378.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2937_CR13","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1097\/QAD.0000000000000428","volume":"28","author":"TM Gibson","year":"2014","unstructured":"Gibson TM, Morton LM, Shiels MS, Clarke CA, Engels EA. Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study. AIDS. 2014;28:2313\u20138.","journal-title":"AIDS"},{"key":"2937_CR14","first-page":"166","volume":"7","author":"J Orem","year":"2007","unstructured":"Orem J, Mbidde EK, Lambert B, de Sanjose S, Weiderpass E. Burkitt\u2019s lymphoma in Africa, a review of the epidemiology and etiology. Afr Health Sci. 2007;7:166\u201375.","journal-title":"Afr Health Sci"},{"key":"2937_CR15","unstructured":"Simbayi L, Zuma K, Zungu N, Moyo S, Marinda E, Jooste S, et al. South African national HIV prevalence, incidence, behaviour and communication survey, 2017. Cape Town: HSRC Press; 2019."},{"key":"2937_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ijc.34236","volume":"152","author":"M Sengayi\u2010Muchengeti","year":"2023","unstructured":"Sengayi\u2010Muchengeti M, Singh E, Chen WC, Bradshaw D, de Villiers CB, Newton R, et al. Thirteen cancers associated with HIV infection in a Black South African cancer patient population (1995\u20102016). Int J Cancer. 2023;152:183\u201394.","journal-title":"Int J Cancer"},{"key":"2937_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/QAI.0000000000002768","volume":"88","author":"T Wiggill","year":"2021","unstructured":"Wiggill T, Mayne E, Perner Y, Vaughan J. Changing patterns of lymphoma in the antiretroviral therapy era in Johannesburg, South Africa. J Acquir Immune Defic Syndr 2021;88:252\u201360.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2937_CR18","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/ijc.34618","volume":"153","author":"W Mburu","year":"2023","unstructured":"Mburu W, Devesa SS, Check D, Shiels MS, Mbulaiteye SM. Incidence of Burkitt lymphoma in the United States during 2000 to 2019. Int J Cancer. 2023;153:1182\u201391.","journal-title":"Int J Cancer"},{"key":"2937_CR19","doi-asserted-by":"publisher","first-page":"e414","DOI":"10.1016\/S1470-2045(15)00162-X","volume":"16","author":"E Singh","year":"2015","unstructured":"Singh E, Ruff P, Babb C, Sengayi M, Beery M, Khoali L, et al. Establishment of a cancer surveillance programme: the South African experience. Lancet Oncol. 2015;16:e414\u201321.","journal-title":"Lancet Oncol"},{"key":"2937_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.7196\/SAMJ.8858","volume":"105","author":"E Singh","year":"2015","unstructured":"Singh E, Underwood JM, Nattey C, Babb C, Sengayi M, Kellett P. South African National Cancer Registry: effect of withheld data from private health systems on cancer incidence estimates. South Afr Med J. 2015;105:107\u20139.","journal-title":"South Afr Med J"},{"key":"2937_CR21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1177\/0049124189018002004","volume":"18","author":"RJA Little","year":"1989","unstructured":"Little RJA, Rubin DB. The analysis of social science data with missing values. Socio Methods Res. 1989;18:292\u2013326.","journal-title":"Socio Methods Res"},{"key":"2937_CR22","unstructured":"Statistics South Africa. Service standards. 2023. https:\/\/www.statssa.gov.za\/?page_id=5365."},{"key":"2937_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/QAI.0000000000002927","volume":"90","author":"LF Johnson","year":"2022","unstructured":"Johnson LF, Meyer-Rath G, Dorrington RE, Puren A, Seathlodi T, Zuma K, et al. The effect of HIV programs in South Africa on national HIV incidence trends, 2000-2019. J Acquir Immune Defic Syndr. 2022;90:115\u201323.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2937_CR24","unstructured":"South African National Department of Health. National consolidated guidelines for the management of HIV in adults, adolescents, children and infants and of prevention of mother-to-child transmission. National Department of Health. 2020."},{"key":"2937_CR25","doi-asserted-by":"crossref","unstructured":"Doll R, Payne P, Waterhouse J. Cancer incidence in five continents: a technical report. Berlin: Spinger-Verlag (for UICC); 1966.","DOI":"10.1007\/978-3-642-85849-9"},{"key":"2937_CR26","unstructured":"Statistics South Africa. General Household Survey 2010. Statistics South Africa 2011."},{"key":"2937_CR27","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/ajh.23187","volume":"87","author":"SM Mbulaiteye","year":"2012","unstructured":"Mbulaiteye SM, Anderson WF, Ferlay J, Bhatia K, Chang C, Rosenberg PS, et al. Pediatric, elderly, and emerging adult-onset peaks in Burkitt\u2019s lymphoma incidence diagnosed in four continents, excluding Africa. Am J Hematol. 2012;87:573\u20138.","journal-title":"Am J Hematol"},{"key":"2937_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/ije\/31.1.37","volume":"31","author":"QA Karim","year":"2002","unstructured":"Karim QA, Karim SSA. The evolving HIV epidemic in South Africa. Int J Epidemiol. 2002;31:37\u201340.","journal-title":"Int J Epidemiol"},{"key":"2937_CR29","doi-asserted-by":"crossref","unstructured":"Karim SSA, Churchyard GJ, Karim QA, Lawn SD. HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet. 2009;374:921\u201333.","DOI":"10.1016\/S0140-6736(09)60916-8"},{"key":"2937_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.7196\/SAMJ.6093","volume":"103","author":"B Puvaneswaran","year":"2012","unstructured":"Puvaneswaran B, Shoba B. Misdiagnosis of tuberculosis in patients with lymphoma. South Afr Med J. 2012;103:32.","journal-title":"South Afr Med J"},{"key":"2937_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/ng.3726","volume":"49","author":"A Dunford","year":"2017","unstructured":"Dunford A, Weinstock DM, Savova V, Schumacher SE, Cleary JP, Yoda A, et al. Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias. Nat Genet. 2017;49:10\u20136.","journal-title":"Nat Genet"},{"key":"2937_CR32","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1182\/blood.2022016534","volume":"141","author":"N Thomas","year":"2023","unstructured":"Thomas N, Dreval K, Gerhard DS, Hilton LK, Abramson JS, Ambinder RF, et al. Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma. Blood. 2023;141:904\u201316.","journal-title":"Blood"},{"key":"2937_CR33","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/bjh.17874","volume":"196","author":"J Richter","year":"2022","unstructured":"Richter J, John K, Staiger AM, Rosenwald A, Kurz K, Michgehl U, et al. Epstein\u2013Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. Br J Haematol. 2022;196:681\u20139.","journal-title":"Br J Haematol"},{"key":"2937_CR34","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/hiv.13179","volume":"23","author":"IKJ Wong","year":"2022","unstructured":"Wong IKJ, Grulich AE, Poynten IM, Polizzotto MN, van Leeuwen MT, Amin J, et al. Time trends in cancer incidence in Australian people living with HIV between 1982 and 2012. HIV Med. 2022;23:134\u201345.","journal-title":"HIV Med"},{"key":"2937_CR35","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1097\/QAD.0000000000001112","volume":"30","author":"LS Park","year":"2016","unstructured":"Park LS, Tate JP, Sigel K, Rimland D, Crothers K, Gibert C, et al. Time trends in cancer incidence in persons living with HIV\/AIDS in the antiretroviral therapy era: 1997-2012. AIDS. 2016;30:1795\u2013806.","journal-title":"AIDS"},{"key":"2937_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijid.2020.10.020","volume":"102","author":"E Majaya","year":"2021","unstructured":"Majaya E, Girdler-Brown BV, Muchengeti M, Singh E. The impact of the South African antiretroviral treatment programme on the age-standardised incidence rate of Kaposi sarcoma, 1999\u20132016: an interrupted time series analysis. Int J Infect Dis. 2021;102:20\u20137.","journal-title":"Int J Infect Dis"},{"key":"2937_CR37","doi-asserted-by":"crossref","unstructured":"Stuart KV, Shepherd DJ, Lombard A, Hollhumer R, Muchengeti M. Incidence and epidemiology of conjunctival squamous cell carcinoma in relation to the HIV epidemic in South Africa: a 25-year analysis of the National Cancer Registry (1994\u20132018). Br J Ophthalmol. 2022;108:175\u201380.","DOI":"10.1136\/bjo-2022-322456"},{"key":"2937_CR38","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/jnci\/94.16.1204","volume":"94","author":"MA Eltom","year":"2002","unstructured":"Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. Trends in Kaposi\u2019s sarcoma and non-Hodgkin\u2019s lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst. 2002;94:1204\u201310.","journal-title":"J Natl Cancer Inst"},{"key":"2937_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01138-z","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang Y, Shen Z, He C, Xing X, Tan Z, Sang W. Global, regional, and national burden of Burkitt lymphoma from 1990 to 2021 and predictions to 2030: a systematic analysis for the Global Burden of Disease Study 2021. Blood Cancer J. 2024;14:154.","journal-title":"Blood Cancer J"},{"key":"2937_CR40","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","volume":"117","author":"E Campo","year":"2011","unstructured":"Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117:5019\u201332.","journal-title":"Blood"},{"key":"2937_CR41","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa055351","volume":"354","author":"M Hummel","year":"2006","unstructured":"Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TFE, et al. A biologic definition of Burkitt\u2019s lymphoma from transcriptional and genomic profiling. N Engl J Med. 2006;354:2419\u201330.","journal-title":"N Engl J Med"},{"key":"2937_CR42","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa055759","volume":"354","author":"SS Dave","year":"2006","unstructured":"Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma E-J, et al. Molecular diagnosis of Burkitt\u2019s lymphoma. N Engl J Med. 2006;354:2431\u201342.","journal-title":"N Engl J Med"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02937-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02937-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02937-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T11:48:54Z","timestamp":1741348134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02937-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,3,23]]}},"alternative-id":["2937"],"URL":"https:\/\/doi.org\/10.1038\/s41416-024-02937-8","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"7 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted under an ethical waiver (W-CBP-230118-01) granted by the University of the Witwatersrand\u2019s Human Research Ethics Committee. This waiver allows the National Cancer Registry to fulfil its legislative mandate for cancer surveillance in South Africa and to support related research. The waiver permits researchers at the registry to publish epidemiological analyses based on routinely collected data without requiring individual informed consent or additional ethical approvals. All procedures in this study adhered to the ethical principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}